Facebook tracking pixel
F03.91
ICD-10-CM
Agitated Dementia

Understanding Agitated Dementia: Find information on dementia with agitation, including behavioral disturbance in dementia. This resource covers clinical documentation, medical coding, healthcare guidelines, and best practices for diagnosing and managing agitated dementia. Learn about symptoms, assessment, and treatment strategies for improved patient care.

Also known as

Dementia with Agitation
Behavioral Disturbance in Dementia

Diagnosis Snapshot

Key Facts
  • Definition : A decline in cognitive function with significant behavioral changes like restlessness, aggression, or wandering.
  • Clinical Signs : Memory loss, confusion, difficulty with daily tasks, plus agitation, irritability, and emotional outbursts.
  • Common Settings : Nursing homes, assisted living facilities, memory care units, and sometimes at home with caregiver support.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F03.91 Coding
F02-F09

Dementia in other diseases

Dementia caused by conditions like Alzheimer's or vascular disease.

F01-F01

Vascular dementia

Dementia due to impaired blood flow to the brain.

G30-G30

Alzheimers disease

Progressive neurodegenerative disease causing memory loss and cognitive decline.

F60-F69

Personality and behavioral disorders

Enduring patterns of inner experience and behavior deviating from cultural norms.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the dementia diagnosis Alzheimer's disease?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Dementia with disruptive behaviors.
General term for cognitive decline.
Dementia caused by vascular disease.

Documentation Best Practices

Documentation Checklist
  • Document specific agitated behaviors (e.g., pacing, verbal outbursts).
  • Note frequency, duration, and severity of agitation.
  • Assess for underlying medical causes of agitation.
  • Document impact on patient's function and safety.
  • Record non-pharmacological and pharmacological interventions.

Coding and Audit Risks

Common Risks
  • Unspecified Dementia Type

    Coding Agitated Dementia without specifying the underlying dementia type (e.g., Alzheimer's) can lead to rejected claims and inaccurate severity reflection.

  • Symptom vs. Diagnosis Coding

    Incorrectly coding agitation symptoms separately, rather than using the combination code for Agitated Dementia, can lead to overcoding and compliance issues.

  • Lack of Supporting Documentation

    Insufficient documentation of behavioral disturbances and cognitive decline can result in claim denials and difficulty in justifying the Agitated Dementia diagnosis.

Mitigation Tips

Best Practices
  • 1. CDI: Document agitation specifics (frequency, triggers). ICD-10: F02.81
  • 2. Compliance: Prioritize non-pharmacological interventions. CMS guidelines.
  • 3. Coding: Code underlying dementia type + agitation codes. G30.9, F02.81
  • 4. CDI: Assess for pain, discomfort, infection as triggers. Review MAR.
  • 5. Compliance: Regularly review/adjust medications for efficacy and safety.

Clinical Decision Support

Checklist
  • 1. Verify dementia diagnosis (e.g., F00-F03, G30, G31.1) documented.
  • 2. Confirm agitation symptoms: aggression, restlessness, irritability.
  • 3. Assess for contributing factors: pain, infection, medication side effects.
  • 4. Rule out delirium (F05), other psychiatric disorders (F06-F99).

Reimbursement and Quality Metrics

Impact Summary
  • Agitated Dementia (A) Reimbursement: Impacts coding for behavioral health services, impacting CMS reimbursement.
  • Coding Accuracy: Precise documentation required for agitated dementia (A) diagnosis, differentiating it from other dementias affects claims accuracy.
  • Hospital Reporting: Agitated dementia (A) impacts quality metrics related to behavioral health outcomes and restraint use.
  • Quality Metrics Impact: Accurate agitated dementia (A) coding affects publicly reported quality measures and value-based payments.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective non-pharmacological interventions for managing agitation in patients with a diagnosis of agitated dementia?

A: Non-pharmacological interventions are often the first line of treatment for agitation in dementia. These approaches aim to address underlying triggers and improve the patient's quality of life. Some of the most effective strategies include creating a calm and structured environment, incorporating personalized activities that cater to the patient's remaining abilities and interests, and employing behavioral modification techniques such as positive reinforcement. Sensory stimulation therapies, like music or aromatherapy, can also be beneficial. Furthermore, caregiver education and support are crucial for consistent implementation and success. Explore how a multidisciplinary approach, involving occupational therapy, social work, and caregiver training, can optimize outcomes for patients with agitated dementia. Consider implementing regular assessments to monitor the effectiveness of these interventions and adjust the care plan as needed.

Q: How can I differentiate between agitation caused by dementia and delirium in a geriatric patient presenting with behavioral disturbances?

A: Differentiating between agitation related to dementia and delirium requires careful assessment of the patient's history, cognitive status, and overall clinical picture. Delirium typically has a rapid onset, fluctuating course, and is often associated with an identifiable medical cause such as an infection or medication side effect. In contrast, agitation in dementia tends to develop more gradually and is a core feature of the disease process. Key distinguishing factors include the presence of altered consciousness, attention deficits, and perceptual disturbances, which are more prominent in delirium. Thorough physical examination, laboratory tests, and review of medications are crucial to identify potential underlying medical conditions. Learn more about validated assessment tools, like the Confusion Assessment Method (CAM), to aid in accurate diagnosis and guide appropriate management strategies. Consider implementing standardized protocols to ensure consistent and timely assessment of patients presenting with behavioral disturbances.

Quick Tips

Practical Coding Tips
  • Code F02.81 for agitated dementia
  • Document agitation specifics
  • Query physician if unclear
  • Check for underlying causes
  • Consider G30.9 if unspecified

Documentation Templates

Patient presents with symptoms consistent with a diagnosis of Agitated Dementia (also known as Dementia with Agitation or Behavioral Disturbance in Dementia).  The patient exhibits a progressive decline in cognitive function, including memory impairment, impaired judgment, and difficulty with executive functioning.  These cognitive deficits are accompanied by significant agitation, manifested as restlessness, pacing, verbal outbursts, and resistance to care.  The patient's behavioral disturbances are impacting their safety and quality of life, as well as posing challenges for caregivers.  Differential diagnoses considered included delirium, depression, and medication side effects.  These were ruled out based on clinical presentation, laboratory results, and review of the patient's medication history.  The patient's Mini-Mental State Examination (MMSE) score is [Insert Score], indicating [Severity of Cognitive Impairment].  Assessment for underlying medical conditions contributing to agitation, such as pain, infection, or metabolic imbalances, is negative.  Non-pharmacological interventions, including environmental modifications and behavioral therapies, will be implemented.  Pharmacological management with [Medication Name and Dosage] is being initiated to target the agitation symptoms.  The patient's family has been educated on the diagnosis, prognosis, and management strategies for Agitated Dementia.  Follow-up appointments are scheduled to monitor symptom progression, medication effectiveness, and caregiver burden.  ICD-10 code F02.81 (Dementia in other diseases classified elsewhere with behavioral disturbance) is documented for medical billing and coding purposes.  Continued assessment and adjustment of the treatment plan will be based on the patient's response and evolving needs.